説明
Summary of clinical and preclinical evidence supporting CAM approaches for modulating Th17 responses in multiple sclerosis and other neuroimmune conditions.
Figure 6
Source Paper
The Role of Th17 in Neuroimmune Disorders: Target for CAM Therapy. Part II.Evidence-based complementary and alternative medicine : eCAM (2011)
PMID: 19622601
DOI: 10.1093/ecam/nep063
Cite This Figure
![Figure 6: Summary of clinical and preclinical evidence supporting CAM approaches for modulating Th17 responses in multiple sclerosis and other neuroimmune conditions.]() > Source: Aristo Vojdani et al. "The Role of Th17 in Neuroimmune Disorders: Target for CAM Therapy. Part II.." *Evidence-based complementary and alternative medicine : eCAM*, 2011. PMID: [19622601](https://pubmed.ncbi.nlm.nih.gov/19622601/)
<figure> <img src="" alt="Summary of clinical and preclinical evidence supporting CAM approaches for modulating Th17 responses in multiple sclerosis and other neuroimmune conditions." /> <figcaption>Figure 6. Summary of clinical and preclinical evidence supporting CAM approaches for modulating Th17 responses in multiple sclerosis and other neuroimmune conditions.<br> Source: Aristo Vojdani et al. "The Role of Th17 in Neuroimmune Disorders: Target for CAM Therapy. Part II.." <em>Evidence-based complementary and alternative medicine : eCAM</em>, 2011. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/19622601/">19622601</a></figcaption> </figure>